Cycloxaprid Patent Landscape Analysis

Discovered at East China University of Science and Technology and advanced by Shanghai Shengnong, cycloxaprid is a cis-neonicotinoid insecticide developed for sucking and chewing pests.

The report retains 124 patent families across 64 consolidated owner groups. Combination development is the largest layer, comprising 87 insecticide combination families; 18 formulation and delivery families and 12 upstream families spanning compound, solid form and process complete the retained set.

A total of 58 families have a grant or national pending reading, while 9 live families reach their nominal term within five years. All 124 families are held by China-based applicants.

This 54-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, followed by a complete directory of all 64 owner groups. Detailed patent tables identify holder, parent filing, claimed subject matter, priority, family members, status and term for every retained family.

Not a freedom-to-operate opinion.